Furthermore, the ROC curve demonstrated that CD44 might play a role as a predictor of subtypes of CL and MS in GBM and pan-gliomas cases (AUC value = 0.833; AUC value = 0.782, Figures S2D, F). This evidence concerns the gene CD44 and glioma.